European Medicines Agency Advanced Pharmacovigilance Auditing and Inspections Course (May 18-19, 2022)
Dublin, April 19, 2022 (GLOBE NEWSWIRE) -- The "Advanced Pharmacovigilance Auditing and Inspections Course" training has been added to ResearchAndMarkets.com's offering.
PV Audit Strategy Planning course will provide an overview of the European Medicines Agency's (EMA) Guideline on good pharmacovigilance practices (GVP), Module IV requires that risk-based audits of the quality system be performed at regular intervals to assure that it complies with the established quality requirements and to determine its effectiveness.
It includes an audit of the pharmacovigilance system which is covered by the quality system. The GVP Modules are applicable to EU-based companies and any company marketing medicinal products on a global basis. The legally required risk-based audit strategy shall cover all PV processes and tasks undertaken by or delegated to other departments, MAH affiliates, and third parties such as distributors, external service providers, partners (the PV Universe). The PV Audit Strategy Plan is used to prepare the PV audit program, i.e. annual PV Audit Schedule.
This two-day workshop conference will review the EMA and FDA requirements regarding Risk-Based Audits of the PV system and Quality System. The course will focus on the design of the PV audit strategy, identification of the PV processes and entities subject to PV audit (define the PV audit universe), development of risk assessment methodology, development of procedures/tools to monitor PV processes and activities, and implementation of the PV audit strategy plan. Additionally, it will review methods of quality oversight and management of third parties performing PV activities.
Agenda
Day 1
Introductions
Regulations
ICH - Guidance US/EU/Japan
ICH Q10 - Pharmaceutical Quality System
Life time of a Product
Resources to monitor the QS
ICH Q9 - Quality Risk Management
Risk Management Methods and Tools
ICH E2- Clinical Safety Data Management
21 CFR Part 314:80/81
EU GVP Module IV (R1) - PV audits (12AUG2015)
Risk Based approach
Strategic Level (2-5 years)
Tactical level
Operational level
Pharmacovigilance System Master File
GVP Module II - PSMF (31MAR2017)
Main body covers the PV QMS including QA
Annex G - Quality System:
Audit schedules
Lst of audits conducted and completed
Significant CAPAs
Background & Design of QA Programme
Strategic Level - Plan to cover:
All pharmacovigilance activities
The Quality Management System (QMS) for pharmacovigilance activities
Interactions with other company departments, as appropriate (GMP, Regulatory Affairs)
Pharmacovigilance activities conducted by affiliated organisations
Pharmacovigilance activities conducted by third parties
Strategic Level
Service Level Agreements - outlines
SDEA
Key Performance Indicators (KPI)
Tactical Level Planning
Tactical Aspects
Operational Level
Pre-Audit Questionnaires
BREAK
Case study/Exercise with Q&A
Implementation of a PVQA Audit Programme
Exercise - Design a QA Audit Programme for Company A
Some questions to consider
End of Day 1
Day 2
Q&A session from Day 1
PV Inspections
EU GVP Module III - PV Inspections (16SEP2014)
EMA Remote PV Inspections - During crisis situations(SEP2020)
MHRA guidance on Remote Inspections
Routine Inspections
Pre-Authorisation Inspections
'For Cause' Inspection
Preparing for a PV Inspection
Tools
Inspection Checklist (Plan) should cover
Document Request form
Metrics from MHRA 2020 Symposium, London
SMART Responses when drafting CAPAs
Audit & Inspection findings
Questions to consider
Case Study 1
Case Study 2
Case Study 3
Q&A session
For more information about this training visit https://www.researchandmarkets.com/r/2yy457
About ResearchAndMarkets.com
ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.
CONTACT: CONTACT: ResearchAndMarkets.com Laura Wood, Senior Press Manager press@researchandmarkets.com For E.S.T Office Hours Call 1-917-300-0470 For U.S./CAN Toll Free Call 1-800-526-8630 For GMT Office Hours Call +353-1-416-8900